TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
CTNM

Contineum Therapeutics, Inc.

Healthcare · Biotechnology

12.70$ -3.0% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Contineum Therapeutics, Inc. (CTNM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 250 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CTNM
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
139 130 124 221 216 213 198 183 191 277 261 250
138 128 120 220 215 206 192 177 185 268 253 243
18 16 16 77 41 22 22 21 43 76 20 15
135 125 118 219 214 205 191 175 182 263 246 237
200 198 199 3.9 5.8 15 13 11 10 16 11 11
7.4 5.5 6.2 3.7 5.8 10.0 8.9 7.2 6.4 9.7 6.7 6.5
1.1 0.5 0.5 0.5 0.6 1.5 1.5 1.5 1.5 2.3 2.3 2.4
1.1 0.6 0.6 0.7 1.4 1.8 3.6 2.0 0.8 1.0 1.5 0.5
-61 -68 -76 218 210 198 185 171 180 261 250 240
-67 -75 -84 -93 -103 -117 -133 -149 -162 -177 -192 -207
25 25 26 26 26 26 26 26 28 31 37 37

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?